Embryonic stem cells can enhance the expression level of Col II in the cartilage matrix and reduce the expression of ADAMTS5, providing a new target for the development of osteoarthritis drugs and drug delivery systems [122]. This evidence concerns the gene ADAMTS5 and osteoarthritis.